The UK Endovascular Aneurysm Repair (EVAR) trials: Design, methodology and progress

European Journal of Vascular and Endovascular Surgery

Volumn 27, Issue 4, 2004, Pages 372-381

  Brown, L C ^a   Epstein, D ^b   Manca, A ^b   Beard, J D ^c   Powell, J T ^d   Greenhalgh, R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

Abdominal aortic aneurysm; Endovascular aneurysm repair; Randomized controlled trial

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ADULT; ANEURYSM SURGERY; AORTA; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENDOVASCULAR SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STENT; SURGICAL MORTALITY; SURGICAL TECHNIQUE; UNITED KINGDOM;

EID: 1642311861     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2003.12.019     Document Type: Article

References (32)

1. Fowkes FGR, MacIntyre CCA, Ruckley CV. Increasing incidence of AA in England and Wales. BMJ 1989;298:33-35.
2. Parodi JC, Palma JC, Barone HD. Transfermoral intraluminal graft implantation for abdominal aortic aneurysm. Ann Vasc Surg 1991;5:491-497.
3. Andrews SM, Cuming R, MacSweeney ST, Barrett NK, Greenhalgh RM, Nott DM. Assessment of feasibility for endovascular prosthetic tube correction of aortic aneurysm. Br J Surg 1995;7:917.
4. Yusef SW, Baker DM, Hind RE et al. Endoluminal transfemoral abdominal aortic aneurysm repair with aorto-uni-iliac graft and femorofemoral bypass. Br J Surg 1995;82:916.
5. Nasim A, Thompson MM, Sayers RD, Bolia A, Bell PRF. Endovascular repair of abdominal aortic aneurysm: an initial experience. Br J Surg 1996;83:516-519.
6. Thomas SM, Gaines PA, Beard JD, On behalf of VSSGBI And BSIR. Short term (30 day) outcome of endovascular treatment of abdominal aortic aneurysms: results from the prospective Registry of Endovascular Treatment of Aneurysms (RETA). Eur J Vasc Endovasc Surg 2001;21:57-64.
7. Harris PL. The need for clinical trials of endovascular abdominal aortic aneurysms stent/graft repair: the EUROSTAR Project. J Endovasc Surg 1997;4:72-77.
8. Harris PL et al. Incidence and risk factors of late rupture, conversion and death after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. J Vasc Surg 2000; 32(4):739-749.
9. The UK. Small Aneurysm Trial Participants. Results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 1998;352:1649-1660.
10. The UK Small Aneurysm Trial Participants, Long-term outcomes of immediate repair compared with surveillance of small aortic aneurysms. NEJM 2002;346(19):1445-1452.
11. Muluk SC, Gertler JP, Brewster DC, Cambria RP et al. Presentation and patterns of aortic aneurysms in young patients. J Vasc Surg 1994;20(6):880-886.
12. D'Angelo J, Pappalo D, Farber A, Murphy AE, Faust GR, Cohen Jon R. Is preoperative cardiac evaluation for abdominal aortic aneurysm repair necessary? J Vasc Surg 1997;25:152-156.
13. White GH, May J. Failure of endovascular repair of abdominal aortic aneurysms: endoleak, adverse events and grading of technical difficulty. In: Greenhalgh RM, ed. The Durability of Vascular and Endovascular Surgery. London: WB Saunders, 1999.
14. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press, 1989.
15. Ware JE, Sherbourne CD. The MOS 36-item short-form health survery (SF-36): conceptual framework and item selection. Med Care 1992;30:473-483.
16. Garratt AM, Ruta DA, Abdalla MI, Buckingham KJ, Russell IT. The SF-36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993;306: 1440-1444.
17. Ruta DA, Abdalla MI, Garratt AM, Russell IT. The SF-36 health survey questionnaire: reliability in patient populations. Qual Health Care 1994;3:180-185.
18. Garratt AM, Russell IT, Abdalla MI. The SF-36 health survey questionnaire: responsiveness to changes in health status in four common clinical conditions. Qual Health Care 1994;3:186-192.
19. The EuroQol Group, EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199-208.
20. Dolan P, Gudex C, Kind P, Williams A. A social tariff for Euroqol: results from a UK general population survey. York Centre for Health Economics Discussion Paper; 1995. pp. 138.
21. Ruta DA, Garratt AM, Leng M, Macdonald LM, Russell IT. A new approach to the measurement of quality of life - the Patient-generated Index. Med Care 1994;11:1109-1126.
22. Bosch JL, Kaufman JA, Beinfeld MT et al. Abdominal aortic aneurysms: cost-effectiveness of elective endovascular and open surgical repair. Radiology 2002;225(2):337-344.
23. Patel ST, Haser PB, Bush HL, Kent KC. The cost-effectiveness of endovascular repair versus open surgical repair of abdominal aortic aneurysms: a decision analysis model. J Vasc Surg 1999; 29(6):958-972.
24. Sternbergh WC, Money SR. Hospital cost of endovascular versus open repair of abdominal aortic aneurysms: a multicentre study. J Vasc Surg 2000;31(2):237-244.
25. Lester JS, Bosch JL, Kaufman JA, Halpern EF, Gazelle GS. Inpatient costs of routine endovascular repair of abdominal aortic aneurysm. Acad Radiol 2001;8(7):639-646.
26. Matthews JNS, Altman DG et al. Analysis of serial measurements in medical research. BMJ 1990;300:230-235.
27. Efron B, Tibshirani R. An Introduction to Bootstrap. New York: Chapman and Hall, 1993.
28. Briggs A, Clark T et al. Missing...presumed at random: cost effectiveness of incomplete data. Health Econ 2003;12(5):377-392.
29. Willan AR, Lin DY, Cook RJ, Chen EB. Using inverse-weighting in cost-effectiveness analysis with censored data. Stat Methods Med Res 2002;11:539-551.
30. Johannesson M, Weinstein S. On the decision rules of cost-effectiveness analysis. J Health Econ 1993;12:459-467.
31. Van Hout BA, Al MJ, Gordon GS et al. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 1994;3(5):309-319.
32. Lilford RJ, Braunholtz DA, Greenhalgh RM, Edwards SJL. Trials and fast changing technologies: the case for tracker studies. BMJ 2000;320:43-46.